Enanta Pharmaceuticals's total assets for Q3 2025 were $301.03M, a decrease of -6.80% from the previous quarter. ENTA total liabilities were $221.75M for the fiscal quarter, a -3.36% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.